2020
DOI: 10.1016/j.bone.2020.115291
|View full text |Cite
|
Sign up to set email alerts
|

Dysregulation of the ghrelin/RANKL/OPG pathway in bone mass is related to AIS osteopenia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
28
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
8

Relationship

3
5

Authors

Journals

citations
Cited by 14 publications
(30 citation statements)
references
References 45 publications
1
28
0
Order By: Relevance
“…The extracted information from each paper, including first author, year of publication, number of cases and controls, and mean levels of leptin and ghrelin, is shown in Table 1 . Among these included 9 articles, 6 articles explored changes of serum leptin and sOB-R in AIS [ 11 , 12 , 17 19 ], another 2 explored changes of ghrelin in AIS [ 21 , 22 ], while the remaining one study both leptin and ghrelin in AIS [ 20 ]. A total of 700 AIS patients and 3536 healthy controls were included for the meta-analysis of leptin, while 198 AIS patients and 138 healthy controls were included for ghrelin analysis.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…The extracted information from each paper, including first author, year of publication, number of cases and controls, and mean levels of leptin and ghrelin, is shown in Table 1 . Among these included 9 articles, 6 articles explored changes of serum leptin and sOB-R in AIS [ 11 , 12 , 17 19 ], another 2 explored changes of ghrelin in AIS [ 21 , 22 ], while the remaining one study both leptin and ghrelin in AIS [ 20 ]. A total of 700 AIS patients and 3536 healthy controls were included for the meta-analysis of leptin, while 198 AIS patients and 138 healthy controls were included for ghrelin analysis.…”
Section: Resultsmentioning
confidence: 99%
“…In addition, Yu et al reported that high ghrelin could serve as a quantitative indicator for predicting curve progression and thus helps in precise selection of treatment in AIS patients [ 20 ]. Xiao et al observed on significant difference in four ghrelin level-related single nucleotide polymorphisms (SNPs) between the AIS osteopenia and control groups, which indicated that abnormally high ghrelin may not result from gene variations, while dysregulation of ghrelin/receptor activator of nuclear factor-kappa beta ligand (RANKL)/osteoprotegerin (OPG) pathway may lead to decreased osteogenic ability of osteoblasts and bone marrow stem cells (BMSCs), which may be related to lower bone mass in AIS osteopenia [ 21 ].…”
Section: Discussionmentioning
confidence: 99%
“…Numerous articles have investigated the relationship between ghrelin and bone mineral density (BMD) with inconsistent results. Xiao et al suggested a dysregulation of ghrelin-regulated pathways that decreases the osteogenic ability of osteoblasts in patients with AIS osteopenia, although they only measured total ghrelin [ 15 ]. Although little is known, there may be differential roles between AG and UAG in BMD.…”
Section: Discussionmentioning
confidence: 99%
“…Recently, the same team reported that ghrelin upregulated the expression of specific genes in the chondrocytes of AIS adolescents, which can lead to abnormal cartilage development [ 14 ]. In 2020, Xiao and colleagues showed dysregulation of the ghrelin/RANKL/OPG pathway in AIS adolescents, which can contribute to osteopenia [ 15 ]. Our recent study showed that, in vitro, ghrelin stimulates differentiation and mineralization of mature osteoblasts through the GHSR/GI/cAMP pathway.…”
Section: Introductionmentioning
confidence: 99%
“…For human primary osteoblast isolation, chopped cancellous bone tissues from the facet joint or posterior column vertebrae were isolated as described before [ 21 ]. In brief, samples were washed with phosphate-buffered solution (PBS) thrice and then incubated with 0.25% trypsin (Gibco, CA, USA) for 30 min at 37°C.…”
Section: Methodsmentioning
confidence: 99%